Novartis Bioventures Ltd Insider Trading $ALT Altimmune, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Novartis Bioventures Ltd.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Novartis Bioventures Ltd. Novartis Bioventures Ltd is 10% Owner in Marina Biotech, Inc. ($MRNA) and 10% Owner in Altimmune, Inc. ($PIP) and 10% Owner in Tokai Pharmaceuticals Inc ($TKAI) and 10% Owner in AILERON THERAPEUTICS INC ($ALRN) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Akebia Therapeutics, Inc. ($AKBA) and in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC).

Novartis Bioventures Ltd in Altimmune, Inc.

Trading Symbol: ALT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 8,345,145 shares
Current Value: $11,432,849
Latest Transaction: Sep 14 2018
$ALT Market Capitalization: $76.74M
$ALT Previous Close: $1.37

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Novartis Bioventures Ltd in Altimmune, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ATRX, AGLE, ARPO, ALRN, AKBA, ALT, BCYC, ELDN, GRTX, RARX, YMTX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Sep 14 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	465,086	1,241,780	0
Sep 14 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	2,069,993	0	8,345,145	6.3 M to 8.3 M (+32.99 %)
Jul 13 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	0
Jul 13 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	663,346	0	6,275,152	5.6 M to 6.3 M (+11.82 %)
Jun 19 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	14,449	0	5,611,806	5.6 M to 5.6 M (+0.26 %)
Jun 15 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	345
Jun 15 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	720,878	0	5,597,357	4.9 M to 5.6 M (+14.78 %)
May 17 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	690
May 17 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	767,728	0	4,876,479	4.1 M to 4.9 M (+18.69 %)
May 17 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	274,703	0	4,108,751	3.8 M to 4.1 M (+7.16 %)
Apr 18 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	1,035
Apr 18 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	217,159	0	3,834,048	3.6 M to 3.8 M (+6.00 %)
Apr 18 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	482,907	0	3,616,889	3.1 M to 3.6 M (+15.41 %)
Mar 19 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	1,380
Mar 19 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	261,969	0	3,133,982	2.9 M to 3.1 M (+9.12 %)
Feb 15 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	1,725
Feb 15 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	67,925	0	2,872,013	2.8 M to 2.9 M (+2.42 %)
Feb 15 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	269,527	0	2,804,088	2.5 M to 2.8 M (+10.63 %)
Jan 19 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	2,070
Jan 19 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	176,586	0	2,534,561	2.4 M to 2.5 M (+7.49 %)
Dec 15 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	2,415
Dec 15 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	65,718	0	2,357,975	2.3 M to 2.4 M (+2.87 %)
Dec 15 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	242,694	0	2,292,257	2 M to 2.3 M (+11.84 %)
Nov 16 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	2,760
Nov 16 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	182,262	0	2,049,563	1.9 M to 2 M (+9.76 %)
Aug 23 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	P	2.67	465,086	1,241,780	465,086
Aug 23 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	P	2.67	3,104	8,288	3,104

Page: 1